Dr. Abdul Hussein Ali Mazin, MD

Dr. Mazin practices at Ascension Saint Alexius in Hoffman Estates, Illinois, part of Ascension Health Alliance.

Dr. Mazin's NPI, 1477500056, was assigned on May 28, 2006. Dr. Mazin graduated from University of Mosul College of Medicine in 1984. Dr. Mazin holds Illinois license 036118947.

Dr. Mazin's primary practice is Ascension Saint Alexius, at 1555 N Barrington Rd, Hoffman Estates, IL 60169 in Cook County. The practice phone is (847) 843-2000.

Dr. Mazin's primary practice is Ascension Saint Alexius in Hoffman Estates, Illinois, part of Ascension Health Alliance. Dr. Mazin is also affiliated with WakeMed Raleigh Campus. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Dr. Mazin to 9 more hospitals, 20 medical groups, 5 group practices and clinics and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mazin practices, 17 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mazin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mazin is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Mazin's licenses on file in 11 states: Illinois, Iowa, Kentucky, Minnesota, North Carolina, Nebraska, Indiana, Ohio, Wisconsin, Massachusetts and New Jersey.

CMS data shows 227 Medicare services from Dr. Mazin across 3 procedure codes in 2024, for 216 Medicare patients. Medicare paid $11,263 for them.

CMS counts 216 Medicare patients who saw Dr. Mazin in 2024. The largest group is 75 to 84, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mazin's median patient age at 27, with 52% women.

In 2024, Dr. Mazin wrote 29 Medicare Part D claims. 48% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $20,943 in total drug cost. In 2019, CMS named 12 claims across 1 drug.

Dr. Mazin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Mazin in 2011. Dr. Mazin's most frequent co-authors are Mahek Mirza, MD, Michael M. Quach, MD and Elie M. Richa, MD.

Dmand AI links Dr. Mazin to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Headache, Migraine Disorders and Headache Disorders, Primary. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Mazin that name 2 trials.

CMS Open Payments shows 97 general payments to Dr. Mazin from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. LivaNova USA, Inc. paid the most, $6,633. It also lists 2 research payments totaling $7,915 from 2021 to 2022, naming 2 clinical trials.

Dr. Mazin graduated from University of Mosul College of Medicine in 1984. Dr. Mazin is a member of AES.

Dr. Mazin is in network with 23 carriers, including Aetna, HCSC and United Healthcare. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.